- Appili Therapeutics press release (OTCPK:APLIF): Q3 net loss and comprehensive loss of C$0.2 million
As of December 31, 2023, the Company had cash of C$0.6 million, compared to C$2.5 million on March 31, 2023.
As of December 31, 2023, the Company had cash of C$0.6 million, compared to C$2.5 million on March 31, 2023.